Parallel Advisors’s Theravance Biopharma TBPH Stock Holding History

Parallel Advisors’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-240	Closed	-$2.26K	–	3662
2024 Q4	$2.26K	Buy	+240	New	+$2.18K	﹤0.01%	2931
2024 Q3	–	Sell	-186	Closed	-$1.58K	–	3469
2024 Q2	$1.58K	Buy	186 +78	+72%	+$704	﹤0.01%	2860
2024 Q1	$969	Sell	108 -1,501	-93%	-$13.9K	﹤0.01%	2939
2023 Q4	$18.1K	Buy	1,609 +1,370	+573%	+$13.8K	﹤0.01%	2002
2023 Q3	$2.06K	Buy	+239	New	+$2.31K	﹤0.01%	2805
2022 Q4	–	Sell	-215	Closed	-$2K	–	3516
2022 Q3	$2K	Buy	+215	New	+$2.02K	﹤0.01%	2761
2022 Q1	–	Sell	-1,899	Closed	-$21K	–	3269
2021 Q4	$21K	Buy	1,899 +994	+110%	+$8.66K	﹤0.01%	1761
2021 Q3	$7K	Buy	905 +747	+473%	+$8.36K	﹤0.01%	2251
2021 Q2	$2K	Hold	158	–	–	﹤0.01%	2615
2021 Q1	$3K	Hold	158	–	–	﹤0.01%	2406
2020 Q4	$3K	Hold	158	–	–	﹤0.01%	2223
2020 Q3	$2K	Hold	158	–	–	﹤0.01%	2350
2020 Q2	$3K	Hold	158	–	–	﹤0.01%	2129
2020 Q1	$3K	Hold	158	–	–	﹤0.01%	2058
2019 Q4	$4K	Hold	158	–	–	﹤0.01%	2056
2019 Q3	$3K	Hold	158	–	–	﹤0.01%	2095
2019 Q2	$3K	Hold	158	–	–	﹤0.01%	2019
2019 Q1	$4K	Hold	158	–	–	﹤0.01%	1898
2018 Q4	$4K	Hold	158	–	–	﹤0.01%	1679
2018 Q3	$5K	Hold	158	–	–	﹤0.01%	1751
2018 Q2	$3K	Sell	158 -35	-18%	-$831	﹤0.01%	1771
2018 Q1	$5K	Hold	193	–	–	﹤0.01%	1586
2017 Q4	$5K	Hold	193	–	–	﹤0.01%	1596
2017 Q3	$5K	Hold	193	–	–	﹤0.01%	1609
2017 Q2	$6K	Hold	193	–	–	﹤0.01%	1542
2017 Q1	$8K	Hold	193	–	–	﹤0.01%	1323
2016 Q4	$6K	Buy	+193	New	+$5.99K	﹤0.01%	1317

Other funds holding TBPH

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ICM

Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Parallel Advisors's TBPH Position: Q1 2025 in Review

Parallel Advisors sold out of Theravance Biopharma (TBPH) in Q1 2025, closing a stake of 240 shares — an estimated $2.26K sold.

Parallel Advisors first reported a position in TBPH in Q4 2016 and held it in 27 quarters. The position peaked at $21K in Q4 2021. 131 funds tracked by Wall St. Rank hold TBPH as of Q1 2025.

Parallel Advisors reported no remaining Theravance Biopharma position as of Q1 2025 after selling out during the quarter.
Parallel Advisors sold 240 Theravance Biopharma shares in Q1 2025, an estimated $2.26K.
Parallel Advisors first reported a position in Theravance Biopharma in Q4 2016 and held it in 27 quarters.
Parallel Advisors's Theravance Biopharma position peaked at $21K in Q4 2021.
131 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2025.

Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.